Myeloproliferative Neoplasms Clinical Trial

STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders

Summary

The purpose of this study is to characterize the safety and efficacy of STA-9090 (ganetespib) in subjects with hematologic malignancies.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria

Males and females 18 years or older
Eligible subjects must have one of the following relapsed or refractory hematologic malignancies: AML, MDS, leukemia-cml/" >CML, or myeloproliferative disorders as defined in the protocol
Must have acceptable organ function during screening as defined in the protocol

Exclusion Criteria

Pregnant or breast-feeding women
Patients must meet the washout periods for prior chemotherapies and radiation
History of stroke within 6 months of treatment
Poor venous access for study drug administration
Treatment with chronic immunosuppressants
Other severe acute/chronic medical or psychiatric condition, or laboratory abnormality that may increase the risk associated with study participation

Study is for people with:

Myeloproliferative Neoplasms

Phase:

Phase 1

Estimated Enrollment:

31

Study ID:

NCT00858572

Recruitment Status:

Completed

Sponsor:

Synta Pharmaceuticals Corp.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You


Boston Massachusetts, 02115, United States

New York New York, 10065, United States

San Antonio Texas, 78229, United States

How clear is this clinincal trial information?

Study is for people with:

Myeloproliferative Neoplasms

Phase:

Phase 1

Estimated Enrollment:

31

Study ID:

NCT00858572

Recruitment Status:

Completed

Sponsor:


Synta Pharmaceuticals Corp.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider